Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 9481 record(s)

Req # A-2023-000931

Adverse Drug Reaction (ADR) for BRIDION. Report number: 000926179. ADRs for CANCIDAS. Report numbers: E2B_04006226, E2B_03524639. ADRs for CUBICIN. Report numbers: 000930030, 000960400. ADR for CUBICIN RF. Report number: 000922609. ADR for CUBICIN, INVANZ. Report number: 000681798. ADR for DAPTOMYCIN. Report number: 000919224.

Organization: Health Canada

66 page(s)
February 2024

Req # A-2023-000947

Adverse Drug Reactions (ADRs) for EMEND. Report numbers: E2B_00593631, 000727906, 000722513, E2B_02464464, E2B_02851048, 000725466, 000926951, 000920381, 000925597, 000925990.

Organization: Health Canada

991 page(s)
February 2024

Req # A-2023-000987

Adverse Drug Reaction (ADR). Report number: 001052651.

Organization: Health Canada

7 page(s)
February 2024

Req # A-2023-001000

Adverse Drug Reaction (ADR). Report number: E2B_06551134.

Organization: Health Canada

21 page(s)
February 2024

Req # A-2023-001034

Adverse Drug Reactions (ADRs) for IMMUNOGLOBULIN (HUMAN). Report numbers: 001051197, E2B_06528820, E2B_06532649, E2B_06572895, E2B_06574977.

Organization: Health Canada

57 page(s)
February 2024

Req # A-2023-001048

Adverse Drug Reaction (ADR). Report number: E2B_06280172.

Organization: Health Canada

23 page(s)
February 2024

Req # A-2023-001064

Adverse Drug Reaction (ADR). Report number: E2B_03453800.

Organization: Health Canada

100 page(s)
February 2024

Req # A-2023-001092

Adverse Drug Reactions (ADRs). Report numbers: E2B_06622636, E2B_06621695.

Organization: Health Canada

56 page(s)
February 2024

Req # A-2023-001098

Adverse Drug Reaction (ADR). Report number: E2B_06564005.

Organization: Health Canada

10 page(s)
February 2024

Req # A-2023-001105

Adverse Drug Reactions (ADRs). Report numbers: E2B_06618356, 000395541.

Organization: Health Canada

159 page(s)
February 2024
Date modified: